Our Portfolio

Myosotis Therapeutics AG

Frank Heppner |

Myosotis Therapeutics AG

Frank Heppner |

Evaluation of the Safety and Efficacy of Ustekinumab in Patients with Mild-to-moderate Alzheimer's Disease

GET IN TOUCH

Alzheimer's Drug Discovery Foundation

A GuideStar-Rated Charity

57 West 57th Street, Suite 904
New York, NY 10019
info@alzdiscovery.org
212.901.8000

© Copyright 2026. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).